Retro Bio

About Retro Bio

Retro Bio develops therapies aimed at meaningfully reversing age-related diseases to extend healthy human lifespan. The company targets cellular drivers of aging to design therapeutics, leveraging approaches like single-cell multi-omics, pooled perturbations, and targeted delivery systems to intervene in aging processes. They pursue translating aging biology insights from proof-of-concept in mammals to human clinical applications, operating with a rapid-iteration, vertically integrated approach. Based in the United States, Retro Bio aspires to become a generational pharma company with a culture of rigor and impact.